Page last updated: 2024-09-05

2'-hydroxyflavanone and Angiogenesis, Pathologic

2'-hydroxyflavanone has been researched along with Angiogenesis, Pathologic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Awasthi, S; Lelsani, P; Nagaprashantha, LD; Prokai, L; Singhal, J; Singhal, SS; Vatsyayan, R	1

Other Studies

1 other study(ies) available for 2'-hydroxyflavanone and Angiogenesis, Pathologic

Article	Year
2'-hydroxyflavanone inhibits proliferation, tumor vascularization and promotes normal differentiation in VHL-mutant renal cell carcinoma. Carcinogenesis, 2011, Volume: 32, Issue:4 Topics: 20-Hydroxysteroid Dehydrogenases; Animals; Carcinoma, Renal Cell; Cell Cycle; Cell Differentiation; Cell Line, Tumor; Cell Movement; Cell Proliferation; ErbB Receptors; Flavanones; Glutathione S-Transferase pi; Humans; Kidney Neoplasms; Mice; Mutation; Neovascularization, Pathologic; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Von Hippel-Lindau Tumor Suppressor Protein; Xenograft Model Antitumor Assays	2011

Article

Year

2'-hydroxyflavanone inhibits proliferation, tumor vascularization and promotes normal differentiation in VHL-mutant renal cell carcinoma.

Carcinogenesis, 2011, Volume: 32, Issue:4

Topics: 20-Hydroxysteroid Dehydrogenases; Animals; Carcinoma, Renal Cell; Cell Cycle; Cell Differentiation; Cell Line, Tumor; Cell Movement; Cell Proliferation; ErbB Receptors; Flavanones; Glutathione S-Transferase pi; Humans; Kidney Neoplasms; Mice; Mutation; Neovascularization, Pathologic; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Von Hippel-Lindau Tumor Suppressor Protein; Xenograft Model Antitumor Assays

2011